NCT02848885View on ClinicalTrials.gov

The Effects of tDCS on Illness Awareness in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

May 13, 2025

Study Completion Date

May 13, 2025

Conditions
Schizophrenia
Interventions
OTHER

Active TDCS

Participants will receive active tDCS stimulation.

OTHER

Sham TDCS

Participants will receive sham tDCS stimulation

Trial Locations (1)

M5S 2S1

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors
lead

Centre for Addiction and Mental Health

OTHER

NCT02848885 - The Effects of tDCS on Illness Awareness in Schizophrenia | Biotech Hunter | Biotech Hunter